Concepedia

Publication | Closed Access

Phase II Trial of Carboxyamidotriazole in Patients With Relapsed Epithelial Ovarian Cancer

DOI

88

Citations

38

References

2003

Year

Mahrukh M. Hussain, Herbert L. Kotz, Lori M. Minasian, Ahalya Premkumar, Gisele Sarosy, Eddie Reed, Suoping Zhai, Seth M. Steinberg, Miranda Raggio, Vyta Kulpa Oliver,
Journal of Clinical Oncology

Abstract

CAI is a potential agent for additional study in the stabilization of relapsed ovarian cancer. Given a limited toxicity profile, it may have utility as a maintenance therapeutic agent for this disease.

References

YearCitations

Page 1